GlassScriptPhysician profile
Danalynn Guasteferro
NPI 1881878296
$4,634.43
in general payments reported to CMS, 2019-2025
16 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,438 · 2020: $369 · 2021: $162 · 2022: $213 · 2023: $83.26 · 2024: $70.93 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $3,346.69 | 2019-2022 | |
| Smith+Nephew, INC. | $263.47 | 2019-2025 | Renasys Go V2 Home |
| Allergan, INC. | $250.65 | 2021-2022 | |
| Organogenesis INC. | $224.44 | 2019-2025 | Puraply, Apligraf |
| Osiris Therapeutics INC. | $140.87 | 2019 | |
| Bsn Medical INC | $119.34 | 2023-2025 | |
| Hartmann USA, INC. | $107.44 | 2024-2025 | Zetuvit Plus 10x10 P10 |
| Solventum Corporation | $28.20 | 2025 | Activ.A.C. |
| Melinta Therapeutics, LLC | $24.71 | 2025 | Rezzayo, Orbactiv, Kimyrsa |
| Acera Surgical, INC. | $22.20 | 2019 | |
| Urgo Medical North America, LLC | $20.16 | 2024 | Urgok2 |
| Paratek Pharmaceuticals, INC. | $19.98 | 2023 | Nuzyra |
| Tactile Systems Technology INC | $17.25 | 2025 | Nimbl, Flexitouch Plus |
| Convatec INC. | $16.85 | 2025 | |
| Mimedx Group, INC. | $16.73 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $15.45 | 2024 | Tcc-Ez |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danalynn Guasteferro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.